NASDAQ:MASS 908 Devices (MASS) Stock Price, News & Analysis → Just Released: Insider's Secret to Trading Options (From Schaeffer’s Research) (Ad) Free MASS Stock Alerts $5.62 +0.06 (+1.08%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$5.54▼$5.7450-Day Range$5.56▼$7.7252-Week Range$4.85▼$12.51Volume159,155 shsAverage Volume158,720 shsMarket Capitalization$184.95 millionP/E RatioN/ADividend YieldN/APrice Target$14.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get 908 Devices alerts: Email Address 908 Devices MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside149.1% Upside$14.00 Price TargetShort InterestBearish4.84% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.44Based on 3 Articles This WeekInsider TradingSelling Shares$139,955 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.27) to ($1.15) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.35 out of 5 starsMedical Sector486th out of 907 stocksMeasuring & Controlling Devices, Not Elsewhere Classified Industry6th out of 9 stocks 3.5 Analyst's Opinion Consensus Rating908 Devices has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst Coverage908 Devices has received no research coverage in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted4.84% of the float of 908 Devices has been sold short.Short Interest Ratio / Days to Cover908 Devices has a short interest ratio ("days to cover") of 6.9.Change versus previous monthShort interest in 908 Devices has recently increased by 9.52%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend Yield908 Devices does not currently pay a dividend.Dividend Growth908 Devices does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MASS. Previous Next 0.9 News and Social Media Coverage News Sentiment908 Devices has a news sentiment score of -0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.43 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for 908 Devices this week, compared to 1 article on an average week. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, 908 Devices insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $139,955.00 in company stock.Percentage Held by Insiders27.80% of the stock of 908 Devices is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions88.06% of the stock of 908 Devices is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for 908 Devices are expected to grow in the coming year, from ($1.27) to ($1.15) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of 908 Devices is -4.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of 908 Devices is -4.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share Ratio908 Devices has a P/B Ratio of 1.10. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him About 908 Devices Stock (NASDAQ:MASS)908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.Read More MASS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MASS Stock News HeadlinesApril 23, 2024 | businesswire.com908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024April 19, 2024 | msn.comThis Porsche 908/02 “Flunder” Never FlounderedApril 25, 2024 | Banyan Hill Publishing (Ad)The Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.March 28, 2024 | msn.comThe drug users being given phones to rebuild their livesMarch 16, 2024 | finance.yahoo.comMASS Apr 2024 7.500 callMarch 14, 2024 | msn.comChina responds to TikTok ban: 'This will inevitably backfire on the U.S.'March 12, 2024 | businesswire.com908 Devices Trace Chemical Identification Technology Adopted by European AgenciesMarch 7, 2024 | markets.businessinsider.comBuy Rating Affirmed for 908 Devices Amidst PAT Growth and Solid Financial OutlookApril 25, 2024 | TradeSmith (Ad)The A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...March 7, 2024 | insidermonkey.com908 Devices Inc. (NASDAQ:MASS) Q4 2023 Earnings Call TranscriptMarch 5, 2024 | finance.yahoo.com908 Devices Inc (MASS) Reports Growth Amidst Industry HeadwindsMarch 5, 2024 | businesswire.com908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue OutlookMarch 4, 2024 | benzinga.com908 Devices Earnings PreviewMarch 4, 2024 | msn.com908 Devices Q4 2023 Earnings PreviewFebruary 29, 2024 | finance.yahoo.com908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares’ Fully Integrated Cell Therapy Manufacturing PlatformFebruary 29, 2024 | businesswire.com908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares' Fully Integrated Cell Therapy Manufacturing PlatformFebruary 22, 2024 | finance.yahoo.com908 Devices to Participate in Upcoming Investor ConferencesFebruary 22, 2024 | businesswire.com908 Devices to Participate in Upcoming Investor ConferencesFebruary 20, 2024 | finance.yahoo.com908 Devices to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024February 20, 2024 | businesswire.com908 Devices to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024February 9, 2024 | finance.yahoo.comWe're Not Very Worried About 908 Devices' (NASDAQ:MASS) Cash Burn RateFebruary 3, 2024 | finance.yahoo.com908 Devices Inc CFO Griffith Joseph H. IV Sells 15,409 SharesFebruary 2, 2024 | ca.finance.yahoo.comJust Released: RISMedia's 2024 Real Estate Agent & Broker Marketing StudyFebruary 2, 2024 | msn.com2024 Rivian R1T Dual-Motor Review: Better Range, Better ValueFebruary 1, 2024 | finance.yahoo.com908 Devices Inc. (MASS)January 1, 2024 | ca.finance.yahoo.comMASS Feb 2024 12.500 putJanuary 1, 2024 | ca.finance.yahoo.comMASS Aug 2024 12.500 callSee More Headlines Receive MASS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 908 Devices and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/05/2024Today4/25/2024Next Earnings (Confirmed)4/30/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Measuring & controlling devices, not elsewhere classified Sub-IndustryN/A Current SymbolNASDAQ:MASS CUSIPN/A CIK1555279 Webwww.908devices.com Phone857-254-1500FaxN/AEmployees230Year FoundedN/APrice Target and Rating Average Stock Price Target$14.00 High Stock Price Target$14.00 Low Stock Price Target$14.00 Potential Upside/Downside+149.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-36,400,000.00 Net Margins-72.47% Pretax Margin-72.89% Return on Equity-21.09% Return on Assets-17.32% Debt Debt-to-Equity RatioN/A Current Ratio7.71 Quick Ratio7.04 Sales & Book Value Annual Sales$50.23 million Price / Sales3.68 Cash FlowN/A Price / Cash FlowN/A Book Value$5.11 per share Price / Book1.10Miscellaneous Outstanding Shares32,910,000Free Float23,761,000Market Cap$184.95 million OptionableOptionable Beta0.93 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesDr. Kevin J. Knopp Ph.D. (Age 51)Co-Founder, CEO, President & Director Comp: $788.88kDr. Christopher David Brown Ph.D. (Age 49)Co-Founder, Chief Product Officer & Co-Chair of Scientific Advisory Board Comp: $459.7kMr. Joseph H. Griffith IV (Age 49)CFO & Treasurer Comp: $468.98kMr. Steve AraizaCo-FounderMr. Andrew BartfayCo-Founder & Director of Hardware DevelopmentMr. Michael JobinCo-Founder & Director of Product DevelopmentDr. Scott Miller Ph.D.Co-founder & Director of MS EngineeringMr. Michael S. Turner Esq. (Age 57)J.D., Chief Legal & Administrative Officer and Secretary Comp: $97.84kMr. Don Osmer (Age 58)Vice President of Human Resources More ExecutivesKey CompetitorsINmune BioNASDAQ:INMBJointNASDAQ:JYNTCardiff OncologyNASDAQ:CRDFVeruNASDAQ:VERUAtossa TherapeuticsNASDAQ:ATOSView All CompetitorsInsiders & InstitutionsSumitomo Mitsui Trust Holdings Inc.Sold 19,740 shares on 4/19/2024Ownership: 1.709%Granahan Investment Management LLCBought 195,368 shares on 2/15/2024Ownership: 6.296%Iron Triangle Partners LPBought 304,484 shares on 2/14/2024Ownership: 3.968%Platinum Investment Management Ltd.Sold 52,953 shares on 2/14/2024Ownership: 2.415%Nikko Asset Management Americas Inc.Sold 47,960 shares on 2/8/2024Ownership: 1.798%View All Insider TransactionsView All Institutional Transactions MASS Stock Analysis - Frequently Asked Questions Should I buy or sell 908 Devices stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for 908 Devices in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" MASS shares. View MASS analyst ratings or view top-rated stocks. What is 908 Devices' stock price target for 2024? 1 brokers have issued 12-month target prices for 908 Devices' stock. Their MASS share price targets range from $14.00 to $14.00. On average, they anticipate the company's share price to reach $14.00 in the next year. This suggests a possible upside of 149.1% from the stock's current price. View analysts price targets for MASS or view top-rated stocks among Wall Street analysts. How have MASS shares performed in 2024? 908 Devices' stock was trading at $11.22 at the start of the year. Since then, MASS stock has decreased by 49.9% and is now trading at $5.62. View the best growth stocks for 2024 here. When is 908 Devices' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 30th 2024. View our MASS earnings forecast. How can I listen to 908 Devices' earnings call? 908 Devices will be holding an earnings conference call on Tuesday, April 30th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link. How were 908 Devices' earnings last quarter? 908 Devices Inc. (NASDAQ:MASS) posted its quarterly earnings data on Tuesday, March, 5th. The company reported ($0.23) EPS for the quarter, topping the consensus estimate of ($0.26) by $0.03. The business had revenue of $14.40 million for the quarter, compared to analyst estimates of $14.16 million. 908 Devices had a negative net margin of 72.47% and a negative trailing twelve-month return on equity of 21.09%. 908 Devices's revenue was up 24.1% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.31) EPS. What ETFs hold 908 Devices' stock? ETFs with the largest weight of 908 Devices (NASDAQ:MASS) stock in their portfolio include ARK Genomic Revolution ETF (ARKG).Alger 35 ETF (ATFV). What guidance has 908 Devices issued on next quarter's earnings? 908 Devices issued an update on its FY 2024 earnings guidance on Wednesday, March, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $52.0 million-$54.0 million, compared to the consensus revenue estimate of $55.5 million. When did 908 Devices IPO? 908 Devices (MASS) raised $101 million in an IPO on Friday, December 18th 2020. The company issued 6,300,000 shares at $15.00-$17.00 per share. Cowen, SVB Leerink, Stifel and William Blair served as the underwriters for the IPO. Who are 908 Devices' major shareholders? 908 Devices' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (1.71%). Insiders that own company stock include Christopher D Brown, Christopher D Brown, John Kenneweg, Joseph H Iv Griffith, Kevin J Knopp, Mark Spoto, Michael S Turner, Nicolas Barthelemy, Trent A Basarsky and Trent A Basarsky. View institutional ownership trends. How do I buy shares of 908 Devices? Shares of MASS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MASS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 908 Devices Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.